| 标题 |
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18–65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Martin Dreyling; Jeanette Doorduijn; Eva Soca Giné; Mats Jerkeman; J Walewski; et al 出版日期:2026-05-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)